Physician

Mary J Porter, MD

According to 2025 Medicare claims, Mary Porter, MD (NPI: 1689642258) practices pulmonary disease in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is SOUTHEAST LUNG & CRITICAL CARE SPECIALISTS, P.C. (NPI: 1740244276; TIN: 58-2362019) and primary practice location at 31406-1523.

Porter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 608 traditional Medicare patients, billed 5,719 HCPCS/CPT codes, and received $258,486 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,615 prescription claims across 792 beneficiaries totaling $1,551,788 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,018 claims. Open Payments data shows 111 records totaling $2,396. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $250,491 to $258,486. In contrast, Part D prescription costs have risen steadily, from $914,779 to $1,551,788. For DME billing, reported payments declined steadily, from $317,270 to $147,675.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$129K$258K2015 Medicare payment: $250,491 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $221,123 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $217,734 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $197,654 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $207,894 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $172,622 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $164,580 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $144,742 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $155,473 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $258,486 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158327,193$250,491
20167886,453$221,123
20177176,521$217,734
20186935,762$197,654
20196915,986$207,894
20206663,856$172,622
20216263,092$164,580
20226143,163$144,742
20236363,740$155,473
20246085,719$258,486

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$941K$1.9M2015 Drug cost: $914,779 (USD; Tot_Drug_Cst)2016 Drug cost: $1,881,231 (USD; Tot_Drug_Cst)2017 Drug cost: $1,049,314 (USD; Tot_Drug_Cst)2018 Drug cost: $933,600 (USD; Tot_Drug_Cst)2019 Drug cost: $972,873 (USD; Tot_Drug_Cst)2020 Drug cost: $1,103,120 (USD; Tot_Drug_Cst)2021 Drug cost: $1,278,179 (USD; Tot_Drug_Cst)2022 Drug cost: $1,281,787 (USD; Tot_Drug_Cst)2023 Drug cost: $1,738,331 (USD; Tot_Drug_Cst)2024 Drug cost: $1,551,788 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154523,377$914,779
20164943,411$1,881,231
20174953,264$1,049,314
20184603,071$933,600
20195203,216$972,873
20205203,155$1,103,120
20215373,136$1,278,179
20225713,156$1,281,787
20237684,344$1,738,331
20247924,615$1,551,788

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$205K$409K2015 Medicare payment: $409,215 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $326,750 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $258,290 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $232,448 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $201,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $229,265 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $213,034 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $185,725 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $183,768 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $148,020 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151,6185,050$409,215
20161,6514,987$326,750
20171,7835,269$258,290
20181,7505,090$232,448
20191,6264,570$201,539
20201,5404,317$229,265
20211,3663,754$213,034
20221,1703,298$185,725
20231,2363,426$183,768
20241,0273,018$148,020

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more431818$89
94729Test to examine how well the lungs exchange gases350355$38
94727Test to determine lung volumes using gas dilution or washout349353$31
94010Test to measure expiratory airflow and volume299341$19
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's246309$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57227,870$590,190
Breztri AerosphereBudesonide/Glycopyr/Formoterol24210,258$213,359
Prolastin CAlpha-1-Proteinase Inhibitor13364$119,432
Breo ElliptaFluticasone/Vilanterol2068,520$111,160
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr1455,790$84,658

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY64438$41,820
A7031Face mask interface, replacement for full face mask, eachN64150$14,795
A7030Full face mask used with positive airway pressure device, eachN68153$13,536
A7032Cushion for use on nasal mask interface, replacement only, eachN4798$11,403
E1392Portable oxygen concentrator, rentalY48314$11,305

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.111$2,396AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mary J. Porter, MD?

Tedicare shows public-source Medicare data for Mary J. Porter, MD (NPI 1689642258), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary J. Porter, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mary J. Porter, MD?

Mary J. Porter, MD is linked to SOUTHEAST LUNG & CRITICAL CARE SPECIALISTS, P.C. (billing NPI 1740244276) in the available physician profile data.

Does Mary J. Porter, MD have Open Payments data?

Mary J. Porter, MD has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.